7,584.25

+10.00

+0.13%

52,630.00

+132.00

+0.25%

28,024.75

+10.25

+0.04%

Russell 2000 Futures

2,852.50

+3.80

+0.13%

4.8640

+0.0050

+0.10%

19.92

-5.72

-22.31%

4,134.00

+19.50

+0.47%

74,741.61

-428.67

-0.57%

Crude Oil Dec 26

86.13

-0.72

-0.83%

US Private Equity

10,850.15

+89.25

+0.83%

NasdaqGS - Delayed Quote USD

Bruker Corporation (BRKRP)

484.21 +37.58 (+8.41%)

At close: November 9 at 4:00:00 PM EST

Loading Chart for BRKRP

Chart Range Bar

Interval:

In partnership with ChartIQ

The 5 most interesting analyst questions from Bruker’s Q3 2026 earnings call

The 5 most interesting analyst questions from Bruker’s Q3 2026 earnings call

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

3 Small-Cap Stocks We’re Skeptical Of

3 Small-Cap Stocks We’re Skeptical Of

3 Unpopular Stocks with Questionable Fundamentals

3 Unpopular Stocks with Questionable Fundamentals

The 5 Most Interesting Analyst Questions From Bruker’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From Bruker’s Q2 Earnings Call

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

Is Bruker (BRKR) Fairly Valued After Its 52 Week High?

Is Bruker (BRKR) Fairly Valued After Its 52 Week High?

Bruker (BRKR) Is Down 20.0% After Goodwill Impairment-Fueled Q2 Loss Despite Higher Sales

Bruker (BRKR) Is Down 20.0% After Goodwill Impairment-Fueled Q2 Loss Despite Higher Sales

Bruker Corporation Q2 2026 Earnings Call Summary

Bruker Corporation Q2 2026 Earnings Call Summary

Bruker Corp (BRKR) (Q2 2026) Earnings Call Highlights: Organic Growth Returns, Margins Surge, ...

Bruker Corp (BRKR) (Q2 2026) Earnings Call Highlights: Organic Growth Returns, Margins Surge, ...

Mobilize your Website

View Site in Mobile | Classic

Share by: